(Q77380414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

M A Ghanem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T H Van Der Kwast

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J C Den Hollander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M K Sudaryo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R B Mathoera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M M Van den Heuvel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R J Nijman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G J van Steenbrugge

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

3120-3129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Enhanced expression of insulin-like growth factor II is not a necessary event in Wilms' tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of insulin-like growth factor-II transcripts in Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Autocrine growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

The new SIOP (Stockholm) working classification of renal tumours of childhood. International Society of Paediatric Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of HER-2/neu in renal-cell carcinoma. Correlation with histologic subtypes and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Distribution of neu (c-erbB-2) protein in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

The epidermal growth factor receptor as a target for therapy in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011215%2992%3A12%3C3120%3A%3AAID-CNCR10173%3E3.0.CO%3B2-2

10.1002/1097-0142(20011215)92:12<3120::AID-CNCR10173>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753991%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference